InvestSMART

ECS Botanics Holdings Ltd (ASX:ECS)

ALERT: Price-sensitive ASX Announcement for ECS
Current share price for ECS : $0.005 -0.001 (-16.67%)+
Announcement
Release
27 Feb 2026 12:02PM
Price at Release
$0.006
Full Release
download
Summary
ECS Botanics Holdings Ltd reported a significant turnaround in its financial performance for the first half of the fiscal year 2026, with revenue rising 16.5% to $11.34 million. The company achieved a profit before tax of $0.04 million, compared to a loss of $1.98 million in the previous period, and an EBITDA of $0.8 million. ECS generated positive operating cash flow for two consecutive quarters and completed major infrastructure expansions to support year-round production and international growth. The company's direct-to-consumer branded products now account for approximately 60% of total revenue, showcasing its successful transition to a brand-led model. ECS also initiated preparations for launching a new women's health brand, AVANI AVA, expected to boost growth in the latter half of FY26.
Key Points
  • Revenue increased by 16.5% to $11.34 million.
  • Profit before tax of $0.04 million, reversing a previous loss.
  • EBITDA improved to $0.8 million.
  • Two consecutive quarters of positive operating cash flow.
  • Branded products account for 60% of total revenue.
  • Completed infrastructure expansions for year-round production.
  • Launch preparations for new women's health brand AVANI AVA.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.